News

Wayne Griffiths, from Talbot Green, Rhondda Cynon Taf, said his daughter Rhian may still be alive had the vaccine been available when she was a child. HPV is a common group of viruses which can ...
A vial of the Phase 3 Novavax coronavirus vaccine prepared for use in a trial at St. George’s University hospital in London, Oct. 7, 2020. (AP Photo/Alastair Grant, File) WASHINGTON — The ...
Novavax’s shot uses traditional protein-based vaccine technology and is the only alternative to the mRNA shots from Pfizer and Moderna. The drugmaker’s application to the FDA was based on a ...
Large and mid-cap vaccine makers are, as of now, unworried about their 2025 pipelines in the face of research funding declines by the Trump administration and a drop in biotech funding.
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 vaccine as a post-approval commitment, a source familiar with the ...
FRIDAY, April 25, 2025 (HealthDay News) — Novavax’s COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update ...
The two-dose measles mumps and rubella (MMR) vaccine is widely available, with the first dose recommended for children between the ages of 12 and 15 months and the second dose recommended between ...
Novavax's COVID-19 vaccine could soon receive full approval from the U.S. Food and Drug Administration (FDA), the company said Wednesday. The update sent Novavax's stock up more than 21% in early ...
Two doses of the measles, mumps and rubella (MMR) or measles, mumps, rubella and varicella vaccine (MMRV) offer almost 100 per cent effectiveness in the long term. Even so, immunologist Dawn ...
Coverage gaps persist. Misinformation, population growth, humanitarian crises and funding cuts are jeopardizing progress against vaccine-preventable diseases, leaving millions of children ...